drugset

drugset / Trial / NCT04558567

Vogelxo(R) ABPM Study in Hypogandal Men

NCT04558567 ↗

Phase 4 Completed 122 enrolled Upsher-Smith Laboratories

NaSingle-groupOpen-labelSupportive care

Summary

A Phase 4 ABPM study in Hypogonadal Men

Timeline

Start: 2020-08-28
Primary completion: 2023-12-12
Completion: 2024-01-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Testosterone	Small molecule	100 mg	—

Indications